141 related articles for article (PubMed ID: 34170339)
21. RB1, p16, and Human Papillomavirus in Oropharyngeal Squamous Cell Carcinoma.
Berdugo J; Rooper LM; Chiosea SI
Head Neck Pathol; 2021 Dec; 15(4):1109-1118. PubMed ID: 33830464
[TBL] [Abstract][Full Text] [Related]
22. Impact of human papillomavirus status on survival and recurrence in a geographic region with a low prevalence of HPV-related cancer: A retrospective cohort study.
De Cicco R; de Melo Menezes R; Nicolau UR; Pinto CAL; Villa LL; Kowalski LP
Head Neck; 2020 Jan; 42(1):93-102. PubMed ID: 31633252
[TBL] [Abstract][Full Text] [Related]
23. Validation of the ICON-S staging for HPV-associated oropharyngeal carcinoma using a pre-defined treatment policy.
Porceddu SV; Milne R; Brown E; Bernard A; Rahbari R; Cartmill B; Foote M; McGrath M; Coward J; Panizza B
Oral Oncol; 2017 Mar; 66():81-86. PubMed ID: 28249652
[TBL] [Abstract][Full Text] [Related]
24. Prognostic impact of additional HPV diagnostics in 102 patients with p16-stratified advanced oropharyngeal squamous cell carcinoma.
Weiss BG; Anczykowski MZ; Küffer S; Spiegel JL; Bertlich M; Canis M; Ihler F; Kitz J; Jakob M
Eur Arch Otorhinolaryngol; 2021 Jun; 278(6):1983-2000. PubMed ID: 32814982
[TBL] [Abstract][Full Text] [Related]
25. A review of the 8th edition of the AJCC staging system for oropharyngeal cancer according to HPV status.
Machczyński P; Majchrzak E; Niewinski P; Marchlewska J; Golusiński W
Eur Arch Otorhinolaryngol; 2020 Sep; 277(9):2407-2412. PubMed ID: 32342197
[TBL] [Abstract][Full Text] [Related]
26. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.
An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA
Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338
[TBL] [Abstract][Full Text] [Related]
27. Sex-specific aspects in patients with oropharyngeal squamous cell carcinoma: a bicentric cohort study.
Klasen C; Wuerdemann N; Rothbart P; Prinz J; Eckel HNC; Suchan M; Kopp C; Johannsen J; Ziogas M; Charpentier A; Huebbers CU; Sharma SJ; Langer C; Arens C; Wagner S; Quaas A; Klußmann JP
BMC Cancer; 2023 Nov; 23(1):1054. PubMed ID: 37919644
[TBL] [Abstract][Full Text] [Related]
28. [The 8th edition of the TNM staging system-a curse or a blessing for oropharyngeal carcinoma?].
Becker C; Hofauer BG; Mansour N; Ketterer MC; Schulz T; Knopf A
HNO; 2021 Feb; 69(2):89-94. PubMed ID: 32385531
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus co-infection and survival in oral and oropharyngeal squamous cell carcinoma: A study in 235 Brazilian patients.
Silveira HA; Almeida LY; Carlos R; Silva EV; Ferrisse TM; Duarte A; Cardoso SCS; Polanco XBJ; Bufalino A; Ribeiro-Silva A; León JE
Auris Nasus Larynx; 2022 Apr; 49(2):258-270. PubMed ID: 34274177
[TBL] [Abstract][Full Text] [Related]
30. Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.
Horne ZD; Glaser SM; Vargo JA; Ferris RL; Balasubramani GK; Clump DA; Heron DE; Beriwal S
Cancer; 2016 Jul; 122(13):2021-30. PubMed ID: 27111669
[TBL] [Abstract][Full Text] [Related]
31. Risk Factors for Overall Survival Outcome in Surgically Treated Human Papillomavirus-Negative and Positive Patients with Oropharyngeal Cancer.
Wuerdemann N; Wittekindt C; Sharma SJ; Prigge ES; Reuschenbach M; Gattenlöhner S; Klussmann JP; Wagner S
Oncol Res Treat; 2017; 40(6):320-327. PubMed ID: 28558385
[TBL] [Abstract][Full Text] [Related]
32. A Comparison of Prognostic Ability of Staging Systems for Human Papillomavirus-Related Oropharyngeal Squamous Cell Carcinoma.
Husain ZA; Chen T; Corso CD; Wang Z; Park H; Judson B; Yarbrough W; Deshpande H; Mehra S; Kuo P; Decker RH; Burtness BA
JAMA Oncol; 2017 Mar; 3(3):358-365. PubMed ID: 27737449
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of lymph node ratio versus American Joint Committee on Cancer N classification for surgically resected human papillomavirus-associated oropharyngeal squamous cell carcinoma.
Nocon CC; Kuchta K; Bhayani MK
Head Neck; 2021 May; 43(5):1476-1486. PubMed ID: 33415799
[TBL] [Abstract][Full Text] [Related]
34. The evolving landscape of human papillomavirus-related oropharyngeal squamous cell carcinoma at a single institution in Northern Italy.
Morbini P; Alberizzi P; Ferrario G; Capello G; De Silvestri A; Pedrazzoli P; Tinelli C; Benazzo M
Acta Otorhinolaryngol Ital; 2019 Feb; 39(1):9-17. PubMed ID: 30936574
[TBL] [Abstract][Full Text] [Related]
35. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.
O'Sullivan B; Huang SH; Su J; Garden AS; Sturgis EM; Dahlstrom K; Lee N; Riaz N; Pei X; Koyfman SA; Adelstein D; Burkey BB; Friborg J; Kristensen CA; Gothelf AB; Hoebers F; Kremer B; Speel EJ; Bowles DW; Raben D; Karam SD; Yu E; Xu W
Lancet Oncol; 2016 Apr; 17(4):440-451. PubMed ID: 26936027
[TBL] [Abstract][Full Text] [Related]
36. How applicable is the TNM 8 staging for human papillomavirus (HPV) related oropharyngeal squamous cell carcinoma (OPSCC) to a UK population of 106 patients? : A cohort comparison of the TNM 7 and TNM8 staging systems for HPV positive oropharyngeal cancer in a UK population.
Bradish T; Fisher H; Paleri V; Robinson M; Meikle D; Kelly C; O'Hara J
Eur Arch Otorhinolaryngol; 2021 Mar; 278(3):755-761. PubMed ID: 32621245
[TBL] [Abstract][Full Text] [Related]
37. Extranodal Extension Improves AJCC-8 Accuracy in HPV+ Oropharyngeal Cancer in a High-Risk Population.
Burruss CP; Sharrer C; Porterfield JZ; Kejner AE
Laryngoscope; 2023 Oct; 133(10):2621-2626. PubMed ID: 36655591
[TBL] [Abstract][Full Text] [Related]
38. Active HPV infection and its influence on survival in head and neck squamous-cell cancer.
Janecka-Widła A; Mucha-Małecka A; Majchrzyk K; Halaszka K; Przewoźnik M; Słonina D; Biesaga B
J Cancer Res Clin Oncol; 2020 Jul; 146(7):1677-1692. PubMed ID: 32372145
[TBL] [Abstract][Full Text] [Related]
39. Human papilloma virus status evaluation and survival description in selected oropharyngeal and laryngeal squamous cell carcinoma patients from Hungary.
Reka Fejer E; Abram Z; Zs Egyed J; Voidazan S; Toth E; Szentirmay Z; Kasler M
J BUON; 2016; 21(1):168-74. PubMed ID: 27061545
[TBL] [Abstract][Full Text] [Related]
40. [HPV and oropharyngeal squamous cell cancer in the 8th edition of the TNM classification].
Hoffmann M; Tribius S
Laryngorhinootologie; 2018 Sep; 97(9):641-649. PubMed ID: 29361647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
